메뉴 건너뛰기




Volumn 31, Issue 30, 2013, Pages 3065-3071

Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease

Author keywords

Hepatitis B virus; Inflammatory bowel disease; Vaccination

Indexed keywords

ALBUMIN; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HEPATITIS A HEPATITIS B VACCINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 84878966475     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.059     Document Type: Article
Times cited : (29)

References (39)
  • 1
    • 0025239328 scopus 로고
    • Hepatitis B: global importance and need for control
    • discussion S1-3
    • Maynard J.E. Hepatitis B: global importance and need for control. Vaccine 1990, 8(Suppl.):S18-S20. discussion S1-3.
    • (1990) Vaccine , vol.8 , Issue.SUPPL.
    • Maynard, J.E.1
  • 2
    • 1642410856 scopus 로고    scopus 로고
    • Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    • Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
    • (2004) J Viral Hepat , vol.11 , pp. 97-107
    • Lavanchy, D.1
  • 3
    • 0018956669 scopus 로고
    • Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States
    • Szmuness W., Stevens C.E., Harley E.J., Zang E.A., Oleszko W.R., William D.C., et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980, 303:833-841.
    • (1980) N Engl J Med , vol.303 , pp. 833-841
    • Szmuness, W.1    Stevens, C.E.2    Harley, E.J.3    Zang, E.A.4    Oleszko, W.R.5    William, D.C.6
  • 4
    • 0035044859 scopus 로고    scopus 로고
    • Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines
    • Coates T., Wilson R., Patrick G., Andre F., Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001, 23:392-403.
    • (2001) Clin Ther , vol.23 , pp. 392-403
    • Coates, T.1    Wilson, R.2    Patrick, G.3    Andre, F.4    Watson, V.5
  • 5
    • 0026438386 scopus 로고
    • Hepatitis B immunization: vaccine types, efficacy, and indications for immunization
    • Hadler S.C., Margolis H.S. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis 1992, 12:282-308.
    • (1992) Curr Clin Top Infect Dis , vol.12 , pp. 282-308
    • Hadler, S.C.1    Margolis, H.S.2
  • 6
    • 0032126559 scopus 로고    scopus 로고
    • Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection
    • Averhoff F., Mahoney F., Coleman P., Schatz G., Hurwitz E., Margolis H. Immunogenicity of hepatitis B vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998, 15:1-8.
    • (1998) Am J Prev Med , vol.15 , pp. 1-8
    • Averhoff, F.1    Mahoney, F.2    Coleman, P.3    Schatz, G.4    Hurwitz, E.5    Margolis, H.6
  • 7
    • 77957188851 scopus 로고    scopus 로고
    • Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
    • Loras C., Gisbert J.P., Minguez M., Merino O., Bujanda L., Saro C., et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut 2010, 59:1340-1346.
    • (2010) Gut , vol.59 , pp. 1340-1346
    • Loras, C.1    Gisbert, J.P.2    Minguez, M.3    Merino, O.4    Bujanda, L.5    Saro, C.6
  • 8
    • 60749113827 scopus 로고    scopus 로고
    • Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study
    • Loras C., Saro C., Gonzalez-Huix F., Mínguez M., Merino O., Gisbert J.P., et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol 2009, 104:57-63.
    • (2009) Am J Gastroenterol , vol.104 , pp. 57-63
    • Loras, C.1    Saro, C.2    Gonzalez-Huix, F.3    Mínguez, M.4    Merino, O.5    Gisbert, J.P.6
  • 9
    • 77952679364 scopus 로고    scopus 로고
    • Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France
    • Chevaux J.B., Nani A., Oussalah A., Venard V., Bensenane M., Belle A., et al. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis 2010, 16:916-924.
    • (2010) Inflamm Bowel Dis , vol.16 , pp. 916-924
    • Chevaux, J.B.1    Nani, A.2    Oussalah, A.3    Venard, V.4    Bensenane, M.5    Belle, A.6
  • 10
    • 67349134712 scopus 로고    scopus 로고
    • European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
    • Rahier J.F., Ben-Horin S., Chowers Y., Conlon C., De Munter P., D'Haens G., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009, 3:47-91.
    • (2009) J Crohns Colitis , vol.3 , pp. 47-91
    • Rahier, J.F.1    Ben-Horin, S.2    Chowers, Y.3    Conlon, C.4    De Munter, P.5    D'Haens, G.6
  • 11
    • 79951663584 scopus 로고    scopus 로고
    • Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease
    • Gisbert J.P., Chaparro M., Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:619-633.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 619-633
    • Gisbert, J.P.1    Chaparro, M.2    Esteve, M.3
  • 13
    • 84864053061 scopus 로고    scopus 로고
    • Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls
    • Altunoz M.E., Senates E., Yesil A., Calhan T., Ovunc A.O. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls. Dig Dis Sci 2012, 57:1039-1044.
    • (2012) Dig Dis Sci , vol.57 , pp. 1039-1044
    • Altunoz, M.E.1    Senates, E.2    Yesil, A.3    Calhan, T.4    Ovunc, A.O.5
  • 14
    • 84867085427 scopus 로고    scopus 로고
    • Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease
    • Gisbert J.P., Villagrasa J.R., Rodriguez-Nogueiras A., Chaparro M. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease. Am J Gastroenterol 2012, 107:1460-1466.
    • (2012) Am J Gastroenterol , vol.107 , pp. 1460-1466
    • Gisbert, J.P.1    Villagrasa, J.R.2    Rodriguez-Nogueiras, A.3    Chaparro, M.4
  • 15
    • 0024810567 scopus 로고
    • Classification of inflammatory bowel disease
    • discussion 16-9
    • Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6. discussion 16-9.
    • (1989) Scand J Gastroenterol Suppl , vol.170 , pp. 2-6
    • Lennard-Jones, J.E.1
  • 16
    • 84894353884 scopus 로고    scopus 로고
    • Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
    • Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
    • (2005) Can J Gastroenterol , vol.19 , Issue.SUPPL. A , pp. 5-36
    • Silverberg, M.S.1    Satsangi, J.2    Ahmad, T.3    Arnott, I.D.4    Bernstein, C.N.5    Brant, S.R.6
  • 17
    • 38749149901 scopus 로고    scopus 로고
    • European evidence-based consensus on the management of ulcerative colitis: special situations
    • Biancone L., Michetti P., Travis S., Escher J.C., Moser G., Forbes A., et al. European evidence-based consensus on the management of ulcerative colitis: special situations. J Crohns Colitis 2008, 2:63-92.
    • (2008) J Crohns Colitis , vol.2 , pp. 63-92
    • Biancone, L.1    Michetti, P.2    Travis, S.3    Escher, J.C.4    Moser, G.5    Forbes, A.6
  • 18
    • 75149116327 scopus 로고    scopus 로고
    • The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations
    • Van Assche G., Dignass A., Reinisch W., van der Woude C.J., Sturm A., De Vos M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis 2010, 4:63-101.
    • (2010) J Crohns Colitis , vol.4 , pp. 63-101
    • Van Assche, G.1    Dignass, A.2    Reinisch, W.3    van der Woude, C.J.4    Sturm, A.5    De Vos, M.6
  • 19
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
    • Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 20
    • 79955941529 scopus 로고    scopus 로고
    • World Medical Association
    • Declaration of Helsinki, Available from:
    • Declaration of Helsinki World Medical Association. World Med J 2008, 54:120-124. Available from:. http://www.wma.net/.
    • (2008) World Med J , vol.54 , pp. 120-124
  • 21
    • 84861184246 scopus 로고    scopus 로고
    • Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease
    • Gisbert J.P., Menchen L., Garcia-Sanchez V., Marin I., Villagrasa J.R., Chaparro M. Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012, 35:1379-1385.
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 1379-1385
    • Gisbert, J.P.1    Menchen, L.2    Garcia-Sanchez, V.3    Marin, I.4    Villagrasa, J.R.5    Chaparro, M.6
  • 22
    • 36749038197 scopus 로고    scopus 로고
    • Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
    • Kugathasan S., Saubermann L.J., Smith L., Kou D., Itoh J., Binion D.G., et al. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease. Gut 2007, 56:1696-1705.
    • (2007) Gut , vol.56 , pp. 1696-1705
    • Kugathasan, S.1    Saubermann, L.J.2    Smith, L.3    Kou, D.4    Itoh, J.5    Binion, D.G.6
  • 23
    • 84858018642 scopus 로고    scopus 로고
    • Early versus late immune mediated inflammatory diseases
    • Fiocchi C. Early versus late immune mediated inflammatory diseases. Acta Gastroenterol Belg 2011, 74:548-552.
    • (2011) Acta Gastroenterol Belg , vol.74 , pp. 548-552
    • Fiocchi, C.1
  • 24
    • 75749150514 scopus 로고    scopus 로고
    • Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients
    • Veny M., Esteller M., Ricart E., Pique J.M., Panes J., Salas A. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther 2010, 31:561-572.
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 561-572
    • Veny, M.1    Esteller, M.2    Ricart, E.3    Pique, J.M.4    Panes, J.5    Salas, A.6
  • 25
    • 0036223592 scopus 로고    scopus 로고
    • Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine
    • Kardar G.A., Jeddi-Tehrani M., Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine. Scand J Immunol 2002, 55:311-314.
    • (2002) Scand J Immunol , vol.55 , pp. 311-314
    • Kardar, G.A.1    Jeddi-Tehrani, M.2    Shokri, F.3
  • 26
    • 0028345884 scopus 로고
    • Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers
    • de Rave S., Heijtink R.A., Bakker-Bendik M., Boot J., Schalm S.W. Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers. Vaccine 1994, 12:532-534.
    • (1994) Vaccine , vol.12 , pp. 532-534
    • de Rave, S.1    Heijtink, R.A.2    Bakker-Bendik, M.3    Boot, J.4    Schalm, S.W.5
  • 27
    • 0018234123 scopus 로고
    • Vaccines and vaccination programs - special emphasis in malnutrition
    • Faulk W.P., Edsall G. Vaccines and vaccination programs - special emphasis in malnutrition. Am J Clin Nutr 1978, 31:2237-2247.
    • (1978) Am J Clin Nutr , vol.31 , pp. 2237-2247
    • Faulk, W.P.1    Edsall, G.2
  • 28
    • 0019461118 scopus 로고
    • Specificities of albumin receptors and albumin antibodies
    • Thung S.N., Gerber M.A. Specificities of albumin receptors and albumin antibodies. Infect Immun 1981, 32:1292-1294.
    • (1981) Infect Immun , vol.32 , pp. 1292-1294
    • Thung, S.N.1    Gerber, M.A.2
  • 29
    • 84863612761 scopus 로고    scopus 로고
    • Meta-analysis. The impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease
    • Fabrizi F., Dixit V., Martin P., Jadoul M., Messa P. Meta-analysis. The impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease. Dig Dis Sci 2012, 57:1366-1372.
    • (2012) Dig Dis Sci , vol.57 , pp. 1366-1372
    • Fabrizi, F.1    Dixit, V.2    Martin, P.3    Jadoul, M.4    Messa, P.5
  • 30
    • 0034049874 scopus 로고    scopus 로고
    • Glucocorticoids in T cell development and function
    • Ashwell J.D., Lu F.W., Vacchio M.S. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000, 18:309-345.
    • (2000) Annu Rev Immunol , vol.18 , pp. 309-345
    • Ashwell, J.D.1    Lu, F.W.2    Vacchio, M.S.3
  • 31
    • 0018251636 scopus 로고
    • The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels
    • Posey W.C., Nelson H.S., Branch B., Pearlman D.S. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J Allergy Clin Immunol 1978, 62:340-348.
    • (1978) J Allergy Clin Immunol , vol.62 , pp. 340-348
    • Posey, W.C.1    Nelson, H.S.2    Branch, B.3    Pearlman, D.S.4
  • 32
    • 33746646343 scopus 로고    scopus 로고
    • Effects of long-term low-dose corticosteroid therapy on humoral immunity
    • Fedor M.E., Rubinstein A. Effects of long-term low-dose corticosteroid therapy on humoral immunity. Ann Allergy Asthma Immunol 2006, 97:113-116.
    • (2006) Ann Allergy Asthma Immunol , vol.97 , pp. 113-116
    • Fedor, M.E.1    Rubinstein, A.2
  • 33
    • 0002276956 scopus 로고
    • Influenza vaccination in patients with rheumatic diseases. Safety and efficacy
    • Herron A., Dettleff G., Hixon B., Brandwin L., Ortbals D., Hornick R., et al. Influenza vaccination in patients with rheumatic diseases. Safety and efficacy. JAMA 1979, 242:53-56.
    • (1979) JAMA , vol.242 , pp. 53-56
    • Herron, A.1    Dettleff, G.2    Hixon, B.3    Brandwin, L.4    Ortbals, D.5    Hornick, R.6
  • 34
    • 84855399053 scopus 로고    scopus 로고
    • Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease
    • Aikawa N.E., Campos L.M., Silva C.A., Carvalho J.F., Saad C.G., Trudes G., et al. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J Rheumatol 2012, 39:167-173.
    • (2012) J Rheumatol , vol.39 , pp. 167-173
    • Aikawa, N.E.1    Campos, L.M.2    Silva, C.A.3    Carvalho, J.F.4    Saad, C.G.5    Trudes, G.6
  • 35
    • 0027529345 scopus 로고
    • Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma
    • Lahood N., Emerson S.S., Kumar P., Sorensen R.U. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann Allergy 1993, 70:289-294.
    • (1993) Ann Allergy , vol.70 , pp. 289-294
    • Lahood, N.1    Emerson, S.S.2    Kumar, P.3    Sorensen, R.U.4
  • 36
    • 84855708317 scopus 로고    scopus 로고
    • Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines
    • Dotan I., Werner L., Vigodman S., Agarwal S., Pfeffer J., Horowitz N., et al. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis 2012, 18:261-268.
    • (2012) Inflamm Bowel Dis , vol.18 , pp. 261-268
    • Dotan, I.1    Werner, L.2    Vigodman, S.3    Agarwal, S.4    Pfeffer, J.5    Horowitz, N.6
  • 37
    • 29844450347 scopus 로고    scopus 로고
    • Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
    • Kapetanovic M.C., Saxne T., Sjoholm A., Truedsson L., Jonsson G., Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:106-111.
    • (2006) Rheumatology (Oxford) , vol.45 , pp. 106-111
    • Kapetanovic, M.C.1    Saxne, T.2    Sjoholm, A.3    Truedsson, L.4    Jonsson, G.5    Geborek, P.6
  • 38
    • 0035892750 scopus 로고    scopus 로고
    • In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL
    • Via C.S., Shustov A., Rus V., Lang T., Nguyen P., Finkelman F.D. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J Immunol 2001, 167:6821-6826.
    • (2001) J Immunol , vol.167 , pp. 6821-6826
    • Via, C.S.1    Shustov, A.2    Rus, V.3    Lang, T.4    Nguyen, P.5    Finkelman, F.D.6
  • 39
    • 67649472564 scopus 로고    scopus 로고
    • Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor
    • Souto-Carneiro M.M., Mahadevan V., Takada K., Fritsch-Stork R., Nanki T., Brown M., et al. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor. Arthritis Res Ther 2009, 11:R84.
    • (2009) Arthritis Res Ther , vol.11
    • Souto-Carneiro, M.M.1    Mahadevan, V.2    Takada, K.3    Fritsch-Stork, R.4    Nanki, T.5    Brown, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.